|Bid||85.30 x 800|
|Ask||85.46 x 1100|
|Day's Range||84.70 - 86.06|
|52 Week Range||41.25 - 86.06|
|Beta (3Y Monthly)||1.45|
|PE Ratio (TTM)||91.65|
|Earnings Date||Apr 24, 2019 - Apr 29, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||76.88|
NEW YORK, Feb. 19, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companiesRead More...
Technology, Intelligence, and Expert Services Showcased in Booth #2071 Designed to Address Rising Medication Management Costs MOUNTAIN VIEW, Calif. , Feb. 11, 2019 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: ...
Omnicell (OMCL) delivered earnings and revenue surprises of 4.48% and -1.35%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Investors seeking stocks to short may want to look closely at the companies in health care information technology. Warning! GuruFocus has detected 2 Warning Sign with CERN. Although the report didn't cite companies, maybe one of candidates trading higher than warranted is Cerner Corp. (CERN).
On a per-share basis, the Mountain View, California-based company said it had net income of 36 cents. Earnings, adjusted for one-time gains and costs, came to 70 cents per share. The results beat Wall ...
Record yearly GAAP revenues of $787.3 million Record yearly Non-GAAP revenues of $787.3 million 2018 GAAP net income per diluted share of $0.93 Record 2018 Non-GAAP net income per diluted share of $2.09 ...
Company Also Sweeps Category Leader Designations for Central Pharmacy Automation Hardware MOUNTAIN VIEW, Calif. , Feb. 4, 2019 /PRNewswire/ -- Omnicell, Inc. , (NASDAQ: OMCL), has earned top honors in ...
MOUNTAIN VIEW, Calif. , Feb. 1, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, ...
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
According to an American Society of Health-system Pharmacists national survey, pharmacy directors estimate that 76 percent of staff time is spent on non-clinical activities.1 An automated medication management infrastructure empowers pharmacists, nurses, clinicians, and pharmacy staff to focus on patient and clinician satisfaction, leading to improved patient care, fewer errors, enhanced safety, and new opportunities for growth. "As our health system continues to expand, we are constantly striving for excellence in care across our facilities," said Gee Mathen, assistant director of Pharmacy Applications and Technical Services at Texas Children's Hospital.
Thermo Fisher's (TMO) Anatomical Pathology business comes under its Specialty Diagnostics segment catering to customers at healthcare and clinical laboratories.
We are optimistic about the strong and consistent performance of Abbott's (ABT) EPD segment. The company's Diabetes Care business has been hogging the limelight on strength in FreeStyle Libre.
Per the terms of the deal between CVS Health (CVS) and Walmart, the latter will continue to take part in the CVS Caremark PBM commercial and Managed Medicaid retail pharmacy networks.
Neogen's (NEOG) genomic business shows steady growth on acquisitions in Australia and Brazil. Stiff rivalry a cause of concern.
Omnicell, Inc. (NASDAQ:OMCL), which is in the healthcare services business, and is based in United States, saw a double-digit share price rise of over 10% in the past couple of Read More...
Multiple ad agencies are facing concerns mostly due to the disruptions their core customers face. But at today's valuations, most ad stocks are fully pricing in concerns, according to Pivotal Research ...
Omnicell (OMCL) steadily sees a solid uptake of Omnicell XT. It also strikes various deals for the XR2 and IVX Workflow products.
MOUNTAIN VIEW, Calif. , Dec. 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, ...